B&M slashes the price of their perfect coffee table to just £3, and it makes a stylish addition to any chic lounge
IT makes a "versatile and space efficient" addition to any lounge.
And while B&M's Home Collection black tray table was already a bargain after dropping from £12 to £6, it's now had its price slashed to just £3.
2
2
Donna took to the Extreme Couponing and Bargains UK group on Facebook to share her epic find, as she called the table "absolutely gawjus".
"B&M - down to £3 nationwide," she wrote alongside a picture of the boxed table, and how it looked once she'd set it up.
The price reduction is also listed on the B&M website, which describes the table as "a contemporary round, metal table" that's "ideal for living rooms or even bathrooms".
The comments section was immediately filled with people weighing in on the bargain, with one tagging a pal and writing: "Next time your in B&M, look out for this.
"I'd like a couple!"
"That's so nice," another added.
"Keep your eye out for me please!" a third commented.
The popularity of tray tables is showing no sign of taking a nose dive any time soon.
According to the experts at House & Garden, "today's tray tables are versatile and space-efficient, doing their job without a bulky footprint or cumbersome solid elements".
"Unlike so many furnishings, they are neither the preserve of the pared-back and contemporary, nor are they favoured by antique-hunting, cottage dwellers."
'Why is no-one talking about this-' woman says about B&M buy that'll transform her bathroom for 'less than a Domino's'
IKEA's GLADOM tray table is another favourite, thanks to its versatility and the £15 price tag.
"Sturdy - this little table is rock solid and you can remove the top and use it as a tray," one happy customer said of the table.
"Good quality, I purchased two!"
"This is a fantastic little table," another wrote.
"I have two of them in my living room perfect for just having lights on."
"Great wee table, even greater price, definitely recommend it, we liked it so much that we bought another one," a third commented.
How to save money at B&M
Shoppers have saved hundreds of pounds a year by using B&M's scanner app.
The scanner lets you see if an item's price is cheaper than advertised on the shop floor label.
Products that are typically discounted are seasonal items and old stock that B&M is trying to shift.
The app is free to download off the B&M Stores mobile app via Google Play or the Apple App Store.
According to one ex-B&M manager, you'll want to visit your local branch at 10am on a Wednesday too.
Here's how you can join the B&M bargain hunt:
Download the B&M app for free on any smartphone with an App Store or Google Play.
Once you've installed it on your device, click on the option labelled "more" on the bottom, right-hand side of the app home page.
You'll then find an option that says "barcode scanner". Click on this and you'll open a camera screen.
Use the camera to hover over the barcode of the product you wish to check.
If the price comes up as lower, take it to the cash desk and it will automatically scan at the lower price.
You don't need to sign up to the B&M app to use the barcode scanner.
"Great value for money. Ideal for small spaces," someone else said.
"I love that the tray is removable. A great purchase!"
"Fantastic metal table to hold your pot plants, mine is currently holding three orchids," another added.
"Lip on the edge of the table keeps any water from leaking onto the carpets, recommended to anyone with pot plants.
"Great price too!"
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
16 minutes ago
- The Guardian
UK trade secretary to seek exemption from US steel and aluminium tariffs
The UK's trade secretary, Jonathan Reynolds, will meet his US counterpart next week to thrash out a timeline for exempting the UK from US steel and aluminium tariffs after Donald Trump announced he would double them. British officials are seeking clarity on the implications of Trump's announcement on Friday night that he planned to double the tariffs from 25% to 50% from Wedneday 4 June, piling further pressure on global steel trade. Reynolds is expected to meet his US counterpart, Jamieson Greer , at the OECD meeting in Paris next week. He will seek to agree a timeline for implementing the deal agreed to lower steel, aluminium, auto and other product tariffs. A UK government spokesperson said: 'The UK was the first country to secure a trade deal with the US earlier this month and we remain committed to protecting British business and jobs across key sectors, including steel.' 'We are engaging with the US on the implications of the latest tariff announcement and to provide clarity for industry.' The Guardian reported that British officials were intensifying trade talks with the US and hope to see the deal implemented within weeks. A government source said: 'Some countries are viewing the court ruling as an indication that they were right not to negotiate over tariffs. We're taking the opposite view, and trying to get this deal implemented as soon as possible.' Trump and Keir Starmer announced a US-UK trade deal earlier this month under which on British steel and aluminium will be reduced to zero, and tariffs on up to 100,000 British cars a year will be reduced from 25% to 10%. The deal did not cover Trump's blanket 10% tariffs on all foreign imports, which a federal court overturned last week, arguing that the US president had overstepped his powers. An appeals court paused the ruling and said Trump's tariffs could continue while it examines the arguments. The European Commission said on Saturday that it 'strongly' regretted Trump's decision to double steel and aluminium tariffs, and warned that the EU was prepared to retaliate. 'This decision adds further uncertainty to the global economy and increases costs for consumers and businesses on both sides of the Atlantic,' a spokesperson for the commission said, adding that 'the tariff increase also undermines ongoing efforts to reach a negotiated solution'. 'The EU is prepared to impose countermeasures, including in response to the latest U.S. tariff increase.' 'The European Commission is currently finalising consultations on expanded countermeasures. If no mutually acceptable solution is reached, both existing and additional EU measures will automatically take effect on 14 July – or earlier, if circumstances require.'
The Sun
18 minutes ago
- The Sun
Plymouth confirm exit of Wayne Rooney replacement in blunt 13-word statement as chairman sends surprise message
Dear Green Army, I am sorry to have not written earlier after relegation was confirmed, earlier this month. Jane and I had personal issues in the US that forced us to cut short our visit to the UK, and we have been occupied taking care of them for a few weeks. Our thanks to those who sent best wishes, and all is ok now. We are making plans for a return to the UK later this summer. We are disappointed at Miron Muslic's departure – not at his joining a club with a profile such as Schalke, but in the timing and manner of his leaving. We hired Miron in January, giving him a three-and-a-half-year contract. Shortly after his joining us, we also hired the staff he requested, in an assistant head coach, head of elite performance, performance analysis and, a little later, a set-piece coach. A recruitment team was in place for the season, augmented by our securing the services of Stuart Webber, a very experienced and well-regarded Sporting Director, to assist with the post-season rebuild of our squad, along with Tom Randle, who has subsequently joined us on a full-time basis as Head of Recruitment. After the season ended, and with rumours flying that Miron was attracting interest from other clubs, I called him personally and he assured me that he was 100% committed to Argyle. As a result, Miron continued to take part in all recruitment meetings and was involved with interviewing and recruiting players until just last week. His colleagues had no indication that he wanted to leave. Last Saturday, Miron informed the club that he wished to speak with Schalke with a view to joining them. Under his contract, a club wishing to speak with him needs Argyle's prior permission. We were unwilling to give such permission, but Miron informed us that under no circumstances was he going to return to Plymouth. Thus, we reluctantly gave the necessary permission. By making clear his intention never to return, Miron gave us no choice but to move on. We could have insisted on the full compensation and gone to court to enforce his contract but would not have had his services as head coach, and progress on recruiting a replacement would have been blocked. Rather than get mired in a protracted, and highly disruptive, process we settled for an amount of compensation that, while below the contracted sum, is a strong financial outcome for a League One head coach, enabling us to move on positively. As you know, we have been in talks with a prospective new investor in our club for over a year. Those talks led to an application for approval of that investment being lodged with the EFL in February. Unfortunately, negotiations have taken too long and the key information that both we and the EFL required to complete the deal has not been forthcoming. I no longer believe that news of the new investor is imminent. As a result, existing shareholders (I, Argyle Green and the Holliday family) will provide the funds to ensure that we stay on course with our plans. This means making funds available to ensure we have a competitive football budget to aim to return us to the Championship as soon as possible, as well as continued investment in Foulston Park. Our budget next season will be twice that we had the last time we were in League One. These additional funds equate to the same level of financial support that was written into the investor plan for year one. I completely understand that this will be very frustrating for fans, as it is extremely frustrating for me and the rest of the Argyle Board. I have said constantly that my resources can enable us to be a sustainable Championship club, but that if we wish to aspire beyond that we would need new investment. I can provide some of that new investment, with the Holliday family's and Argyle Green's help, but not all. While progress towards a transaction in its current form looks to have stalled, we will continue to explore alternative routes, including being open to revised terms with other investment groups. It is important that we get the right investor, not the quickest investor, and this may take some time. We are committed to this, but in the meantime, current shareholders can (and will) support the club through its next stage of development. This current situation is disappointing, obviously, but honesty and transparency are important to us. It's been a long, ponderous process, but one we thought would come to a successful conclusion. It has not, but we remain in a very strong financial position. Over the past five or six years, we have set out a clear pathway to achieving success at Argyle. In that time, we progressed from League Two to the Championship, where we spent two seasons, before suffering relegation. Our mission has been, and remains, to be a sustainable and competitive Championship club, but some of the decisions we have made in the last two seasons have not worked as we had hoped. Those decisions obviously contributed to our relegation, but were decisions made by the entire board, and it is entirely unfair to blame any individuals. Unfortunately, in sport, as in life, decisions made do not always work out. We are sorry and will do everything we can to put it right. Argyle's long-term strategy is set by the board and executed by Andrew Parkinson, our CEO, and his team. Away from the pitch, the club continues to make significant strides. Thanks to the efforts of all staff, we have seen remarkable off-pitch progress including record revenues this year. We've also been recognised with several industry awards - testament to the quality of work happening every day behind the scenes. This progress is a direct result of the hard work and commitment of staff across all departments. Our focus on sustainable growth has led to significant infrastructure investments that now generate substantial revenue which supports our football operations. The first and still the largest of those investments was the refurbishment of the Mayflower Grandstand. Today, that not only provides outstanding match-day hospitality to our fans, but a facility for businesses and other organisations in the area. The revenues generated now number in the millions, and go directly into the running of the football club, primarily the football budget. The Grandstand refurbishment was the first and remains the biggest investment, but has been followed by the acquisition of Higher Home Park, part of which is now used as the Biffa Fan Zone; by the Green Taverners' building, now the Far Post; by the acquisition of Goals, now Harpers; and by many smaller investments that have improved the experience for fans and sponsors. As a result, the stadium has been full for most home games. We have also invested in players, breaking the club transfer record several times and realising substantial surpluses on subsequent sales of players. The result is that your club is now financially stronger than it has ever been with a strong and diversified revenue base. Those revenues have, until last season, helped lead to our success on the pitch. We have consistently achieved more than would be suggested by what we are able to spend on the first-team squad alone. Sometimes, our results flattered our performances but, overall, the strategy to compete by outsmarting not outspending our competitors has been successful. Last season, it was not, and the board took the decision in January that our best hope of avoiding what by then was a very likely fate was to hire a Head Coach who could introduce a new playing style. We narrowly failed, despite the efforts of our staff and our players. I thank them all. We will play the coming season in League One, as we did three years ago. Our circumstances, though, are much changed, because of the investments we have made and the support you have given us. We will have the financial resources to compete strongly at the top end of the division. Relegation is always disappointing, but we are now in a position where we end up stronger than we began. In the long-term, this is not being a yo-yo club, this is being a club that invests for the long term and emerges stronger from any setbacks. You will know that former Head of Recruitment Jimmy Dickinson has left Argyle after a successful six years. Jimmy has been a positive influence on the club, and we wish him well in the future. We also congratulate Ross Goodwin, our Head of Football Data, who will return home, and take on a senior role as Head of Recruitment at Dundee United. We are delighted to welcome David Fox back to Home Park in a senior management role as Head of Football Operations. He will be responsible for helping formulate and executing strategy on the football side of the club. Initially, he will be aided by Stuart Webber, whose experience and abilities as a Sporting Director will be hugely beneficial to Argyle. David and Stuart have been actively engaged in the process of recruiting a new head coach, and we hope to have an appointment in place as soon as possible. David will be provided with the support, resources and structure he needs. As I mentioned above, we also welcome Tom Randle as Head of Recruitment. He, David and Stuart have already been working behind the scenes to identify and recruit the players who will join us this summer. Recruitment is led by David and Tom, with other senior executive involvement. This structure means recruitment continues regardless of any changes in coaching staff, ensuring alignment with the club's long-term football strategy. We have already seen the fruits of this combined effort, and I'd like to welcome Jamie Paterson, Caleb Watts and Jack MacKenzie to Argyle. I'll be back in the UK over the summer, when we will host a Fans Forum ahead of the new season. I'll be very happy to address the questions I'm sure you will have on the investment setbacks and how we intend to take things forward to achieve our goals. Finally, to you, the fans - you have been outstanding. Week after week, match after match, home or away, your support never wavers, and all at your club are grateful to you. We've never been more determined to succeed and, alongside your unrivalled backing, through the highs and the lows, together we'll do this. See you soon, Simon
Telegraph
19 minutes ago
- Telegraph
Breakthrough breast cancer treatment could help 1,000 women a year
A new triple-drug treatment for aggressive advanced breast cancer can cut deaths by a third, a major trial has found. The international research used liquid biopsies – described as the 'golden key' to unlocking precision medicines – that identified suitable patients. All were suffering from one of the most common forms of breast cancer, which accounts for seven in 10 cases, and had a common mutation which makes it more deadly and aggressive. The three-drug therapy comprises two targeted drugs – palbociclib, a type of cancer growth blocker, and a new drug called inavolisib, which blocks the activity of the PI3K protein – as well as the hormone therapy fulvestrant. Until now, treatment options for such patients have been limited. The trial involving the Institute of Cancer Research and The Royal Marsden NHS Foundation Trust enrolled 325 patients from 28 countries, including the UK. In all cases, cancer had spread or returned after hormone therapy and for those who had not yet received systemic treatment for metastatic disease. Of the total, 161 were given the three-drug combination. The placebo group, which included 164 patients, was given a dummy pill plus palbociclib and fulvestrant. The study found the median overall survival in the inavolisib group was 34 months, compared with 27 months in the placebo group. The therapy was far more likely to result in significant shrinkage of tumours. In total, 62.7 per cent of patients in the inavolisib group saw their tumours shrink by more than 30 per cent, compared with 28 per cent in the placebo group. The randomised, double blind trial also showed that the new combination delayed the progression of the disease by 17.2 months, on average, compared with 7.3 months in the control group. Women taking inavolisib were able to delay subsequent chemotherapy treatment by almost two years longer than the patients in the control group. Around 55,000 women are diagnosed with breast cancer in the UK every year, and 11,500 will die from the disease. The study involved women with one of the most common types of disease, who had a mutation which is more aggressive and deadly. Experts said around 1,000 women a year could be helped by the drug combination. The study, funded by pharmaceutical company Roche, which manufactures inavolisib, was presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago and simultaneously published in The New England Journal of Medicine. Lead author Nick Turner, professor of molecular oncology at the Institute of Cancer Research and consultant medical oncologist at The Royal Marsden NHS Foundation Trust, said the therapy 'not only helped patients live longer, but it more than doubled the time before their cancer progressed or worsened. 'It also gave them more time before needing subsequent chemotherapy, which we know is something that patients really fear and want to delay for as long as possible,' he said. The oncologist said he hoped the triple therapy would become the standard of care for women who can benefit. Previous trial results led the United States Food and Drug Administration (FDA) to grant 'breakthrough therapy' designation for inavolisib in May 2024 with costs of around $23,000 (£17,000) monthly. It has yet to be licensed in the UK. Professor Kristian Helin, chief executive of the Institute of Cancer Research, London, said: 'This research demonstrates how this triple combination approach, effectively shuts down cancer's escape routes, giving people with metastatic breast cancer the opportunity to live well for longer.' Dr Nisharnthi Duggan, research information manager at Cancer Research UK, said: 'These results are really positive news for people living with a type of hard-to-treat breast cancer. The trial showed that adding inavolisib to targeted treatment plans improved survival. On top of this, it also delayed the progression of people's cancer and the need for chemotherapy, which could improve quality of life. 'We hope that more research like this will help to give people kinder cancer treatment options, and more time with their loved ones.'
